42 research outputs found
Newborn skin reflection: Proof of concept for a new approach for predicting gestational age at birth. A cross-sectional study
Current methods to assess the gestational age during prenatal care or at
birth are a global challenge. Disadvantages, such as low accessibility, high
costs, and imprecision of clinical tests and ultrasonography measurements, may
compromise health decisions at birth, based on the gestational age. Newborns
organs and tissues can indirectly indicate their physical maturity, and we
hypothesized that evolutionary changes in their skin, detected using an
optoelectronic device meter, may aid in estimating the gestational age. This
study analyzed the feasibility of using newborn skin reflectance to estimate
the gestational age at birth noninvasively. A cross-sectional study evaluated
the skin reflectance of selected infants, preferably premature, at birth. The
first-trimester ultrasound was the reference for gestational age. A prototype
of a new noninvasive optoelectronic device measured the backscattering of light
from the skin, using a light emitting diode at wavelengths of 470 nm, 575 nm,
and 630 nm. Univariate and multivariate regression analysis models were
employed to predict gestational age, combining skin reflectance with clinical
variables for gestational age estimation. The gestational age at birth of 115
newborns from 24.1 to 41.8 weeks of gestation correlated with the light at 630
nm wavelength reflectance 3.3 mm/6.5 mm ratio distant of the sensor, at the
forearm and sole . The best-combined variables to predict the gold standard
gestational age at birth was the skin reflectance at wavelengths of 630 nm and
470 nm in combination with birth weight, phototherapy, and adjusted to include
incubator stay, and sex. The main limitation of the study is that it was very
specific to the premature population we studied and needs to be studied in a
broader spectrum of newborns
Leading causes of child mortality in Brazil, in 1990 and 2015 : estimates from the Global Burden of Disease study
Objetivo: analisar as taxas de mortalidade e as principais causas de morte na infância no Brasil e estados, entre 1990 e 2015, utilizando estimativas do estudo Carga Global de Doença (Global Burden of Disease - GBD) 2015. Métodos: as fontes de dados foram óbitos e nascimentos estimados com base nos dados do Sistema de Informações sobre Mortalidade (SIM), censos e pesquisas. Foram calculadas proporções e taxas por mil nascidos vivos (NV) para o total de óbitos e as principais causas de morte na infância. Resultados: o número estimado de óbitos para menores de 5 anos, no Brasil, foi de 191.505, em 1990, e 51.226, em 2015, sendo cerca de 90% mortes infantis. A taxa de mortalidade na infância no Brasil sofreu redução de 67,6%, entre 1990 e 2015, cumprindo a meta estabelecida nos Objetivos de Desenvolvimento do Milênio (ODM). A redução total das taxas foi, em geral, acima de 60% nos estados, sendo maior na região Nordeste. A disparidade entre as regiões foi reduzida, sendo que a razão entre o estado com a maior e a menor taxa diminuiu de 4,9, em 1990, para 2,3, em 2015. A prematuridade, apesar de queda de 72% nas taxas, figurou como a principal causa de óbito em ambos os anos, seguida da doença diarreica, em 1990, e das anomalias congênitas, da asfixia no parto e da sepse neonatal, em 2015. Conclusão: a queda nas taxas de mortalidade na infância representa um importante ganho no período, com redução de disparidades geográficas. As causas relacionadas ao cuidado em saúde na gestação, no parto e no nascimento figuram como as principais em 2015, em conjunto com as anomalias congênitas. Políticas públicas intersetoriais e de saúde específicas devem ser aprimoradas.Objective: to analyze under-5 mortality rates and leading causes in Brazil and states in 1990 and 2015, using the Global Burden of Disease Study (GBD) 2015 estimates. Methods: the main sources of data for all-causes under-5 mortality and live births estimates were the mortality information system, surveys, and censuses. Proportions and rates per 1,000 live births (LB) were calculated for total deaths and leading causes. Results: estimates of under-5 deaths in Brazil were 191,505 in 1990, and 51,226 in 2015, 90% of which were infant deaths. The rates per 1,000 LB showed a reduction of 67.6% from 1990 to 2015, achieving the proposed target established by the Millennium Development Goals (MDGs). The reduction generally was more than 60% in states, with a faster reduction in the poorest Northeast region. The ratio of the highest and lowest rates in the states decreased from 4.9 in 1990 to 2.3 in 2015, indicating a reduction in socioeconomic regional disparities. Although prematurity showed a 72% reduction, it still remains as the leading cause of death (COD), followed by diarrheal diseases in 1990, and congenital anomalies, birth asphyxia and septicemia neonatal in 2015. Conclusion: under-5 mortality has decreased over the past 25 years, with reduction of regional disparities. However, pregnancy and childbirth-related causes remain as major causes of death, together with congenital anomalies. Intersectoral and specific public health policies must be continued to improve living conditions and health care in order to achieve further reduction of under-5 mortality rates in Brazil
Factors Associated With Red Blood Cell Transfusions In Very-low-birth-weight Preterm Infants In Brazilian Neonatal Units
Background: Preterm infants in neonatal intensive care units frequently receive red blood cells (RBC) transfusions due to the anemia of prematurity. A number of variables related to gestational age, severity of illness and transfusion practices adopted in the neonatal unit where the neonate was born may contribute to the prescription of RBC transfusions. This study aimed to analyse the frequency and factors associated with RBC transfusions in very-low-birth-weight preterm infants. Methods: A prospective cohort of 4283 preterm infants (gestational age: 29.9 +/- 2.9 weeks; birth weight: 1084 +/- 275 g) carried out at 16 university hospitals in Brazil between January 2009 and December 2011 was analysed. Factors associated with RBC transfusions were evaluated using univariate and multiple logistic regression analysis. Results: A total of 2208 (51.6 %) infants received RBC transfusions (variation per neonatal unit: 34.1 % to 66.4 %). RBC transfusions were significantly associated with gestational age (OR: -1.098; 95% CI: -1.12 to -1.04), SNAPPE II score (1.01; 1.00-1.02), apnea (1.69; 1.34-2.14), pulmonary hemorrhage (2.65; 1.74-4.031), need for oxygen at 28 days of life (1.56; 1.17-2.08), clinical sepsis (3.22; 2.55-4.05), necrotising enterocolitis (3.80; 2.26-6.41), grades III/IV intraventricular hemorrhage (1.64; 1.05-2.58), mechanical ventilation (2.27; 1.74-2.97), use of umbilical catheter (1.86; 1.35-2.57), parenteral nutrition (2.06; 1.27-3.33), > 60 days of hospitalization (5.29; 4.02-6.95) and the neonatal unit where the neonate was born. Conclusions: The frequency of RBC transfusions varied among neonatal intensive care units. Even after adjusting for adverse health conditions and therapeutic interventions, the neonatal unit continued to influence transfusion practices in very-low birth-weight infants.1
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
BACKGROUND: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can identify exemplars for best practice. To accomplish this, the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) estimated age-specific and sex-specific all-cause mortality between 1970 and 2016 for 195 countries and territories and at the subnational level for the five countries with a population greater than 200 million in 2016.
METHODS: We have evaluated how well civil registration systems captured deaths using a set of demographic methods called death distribution methods for adults and from consideration of survey and census data for children younger than 5 years. We generated an overall assessment of completeness of registration of deaths by dividing registered deaths in each location-year by our estimate of all-age deaths generated from our overall estimation process. For 163 locations, including subnational units in countries with a population greater than 200 million with complete vital registration (VR) systems, our estimates were largely driven by the observed data, with corrections for small fluctuations in numbers and estimation for recent years where there were lags in data reporting (lags were variable by location, generally between 1 year and 6 years). For other locations, we took advantage of different data sources available to measure under-5 mortality rates (U5MR) using complete birth histories, summary birth histories, and incomplete VR with adjustments; we measured adult mortality rate (the probability of death in individuals aged 15-60 years) using adjusted incomplete VR, sibling histories, and household death recall. We used the U5MR and adult mortality rate, together with crude death rate due to HIV in the GBD model life table system, to estimate age-specific and sex-specific death rates for each location-year. Using various international databases, we identified fatal discontinuities, which we defined as increases in the death rate of more than one death per million, resulting from conflict and terrorism, natural disasters, major transport or technological accidents, and a subset of epidemic infectious diseases; these were added to estimates in the relevant years. In 47 countries with an identified peak adult prevalence for HIV/AIDS of more than 0·5% and where VR systems were less than 65% complete, we informed our estimates of age-sex-specific mortality using the Estimation and Projection Package (EPP)-Spectrum model fitted to national HIV/AIDS prevalence surveys and antenatal clinic serosurveillance systems. We estimated stillbirths, early neonatal, late neonatal, and childhood mortality using both survey and VR data in spatiotemporal Gaussian process regression models. We estimated abridged life tables for all location-years using age-specific death rates. We grouped locations into development quintiles based on the Socio-demographic Index (SDI) and analysed mortality trends by quintile. Using spline regression, we estimated the expected mortality rate for each age-sex group as a function of SDI. We identified countries with higher life expectancy than expected by comparing observed life expectancy to anticipated life expectancy on the basis of development status alone.
FINDINGS: Completeness in the registration of deaths increased from 28% in 1970 to a peak of 45% in 2013; completeness was lower after 2013 because of lags in reporting. Total deaths in children younger than 5 years decreased from 1970 to 2016, and slower decreases occurred at ages 5-24 years. By contrast, numbers of adult deaths increased in each 5-year age bracket above the age of 25 years. The distribution of annualised rates of change in age-specific mortality rate differed over the period 2000 to 2016 compared with earlier decades: increasing annualised rates of change were less frequent, although rising annualised rates of change still occurred in some locations, particularly for adolescent and younger adult age groups. Rates of stillbirths and under-5 mortality both decreased globally from 1970. Evidence for global convergence of death rates was mixed; although the absolute difference between age-standardised death rates narrowed between countries at the lowest and highest levels of SDI, the ratio of these death rates-a measure of relative inequality-increased slightly. There was a strong shift between 1970 and 2016 toward higher life expectancy, most noticeably at higher levels of SDI. Among countries with populations greater than 1 million in 2016, life expectancy at birth was highest for women in Japan, at 86·9 years (95% UI 86·7-87·2), and for men in Singapore, at 81·3 years (78·8-83·7) in 2016. Male life expectancy was generally lower than female life expectancy between 1970 and 2016, an
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017
Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world's population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data. Methods: We estimated incidence and prevalence for 354 diseases and injuries and 3484 sequelae. We used an updated and extensive body of literature studies, survey data, surveillance data, inpatient admission records, outpatient visit records, and health insurance claims, and additionally used results from cause of death models to inform estimates using a total of 68 781 data sources. Newly available clinical data from India, Iran, Japan, Jordan, Nepal, China, Brazil, Norway, and Italy were incorporated, as well as updated claims data from the USA and new claims data from Taiwan (province of China) and Singapore. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, prevalence, remission, and cause of death for each condition. YLDs were estimated as the product of a prevalence estimate and a disability weight for health states of each mutually exclusive sequela, adjusted for comorbidity. We updated the Socio-demographic Index (SDI), a summary development indicator of income per capita, years of schooling, and total fertility rate. Additionally, we calculated differences between male and female YLDs to identify divergent trends across sexes. GBD 2017 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting. Findings: Globally, for females, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and haemoglobinopathies and haemolytic anaemias in both 1990 and 2017. For males, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and tuberculosis including latent tuberculosis infection in both 1990 and 2017. In terms of YLDs, low back pain, headache disorders, and dietary iron deficiency were the leading Level 3 causes of YLD counts in 1990, whereas low back pain, headache disorders, and depressive disorders were the leading causes in 2017 for both sexes combined. All-cause age-standardised YLD rates decreased by 3·9% (95% uncertainty interval [UI] 3·1-4·6) from 1990 to 2017; however, the all-age YLD rate increased by 7·2% (6·0-8·4) while the total sum of global YLDs increased from 562 million (421-723) to 853 million (642-1100). The increases for males and females were similar, with increases in all-age YLD rates of 7·9% (6·6-9·2) for males and 6·5% (5·4-7·7) for females. We found significant differences between males and females in terms of age-standardised prevalence estimates for multiple causes. The causes with the greatest relative differences between sexes in 2017 included substance use disorders (3018 cases [95% UI 2782-3252] per 100 000 in males vs 1400 [1279-1524] per 100 000 in females), transport injuries (3322 [3082-3583] vs 2336 [2154-2535]), and self-harm and interpersonal violence (3265 [2943-3630] vs 5643 [5057-6302]). Interpretation: Global all-cause age-standardised YLD rates have improved only slightly over a period spanning nearly three decades. However, the magnitude of the non-fatal disease burden has expanded globally, with increasing numbers of people who have a wide spectrum of conditions. A subset of conditions has remained globally pervasive since 1990, whereas other conditions have displayed more dynamic trends, with different ages, sexes, and geographies across the globe experiencing varying burdens and trends of health loss. This study emphasises how global improvements in premature mortality for select conditions have led to older populations with complex and potentially expensive diseases, yet also highlights global achievements in certain domains of disease and injury
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015 : a novel analysis from the Global Burden of Disease Study 2015
Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015. Methods We mapped the most widely used list of causes amenable to personal health care developed by Nolte and McKee to 32 GBD causes. We accounted for variations in cause of death certification and misclassifications through the extensive data standardisation processes and redistribution algorithms developed for GBD. To isolate the effects of personal health-care access and quality, we risk-standardised cause-specific mortality rates for each geography-year by removing the joint effects of local environmental and behavioural risks, and adding back the global levels of risk exposure as estimated for GBD 2015. We employed principal component analysis to create a single, interpretable summary measure-the Healthcare Quality and Access (HAQ) Index-on a scale of 0 to 100. The HAQ Index showed strong convergence validity as compared with other health-system indicators, including health expenditure per capita (r= 0.88), an index of 11 universal health coverage interventions (r= 0.83), and human resources for health per 1000 (r= 0.77). We used free disposal hull analysis with bootstrapping to produce a frontier based on the relationship between the HAQ Index and the Socio-demographic Index (SDI), a measure of overall development consisting of income per capita, average years of education, and total fertility rates. This frontier allowed us to better quantify the maximum levels of personal health-care access and quality achieved across the development spectrum, and pinpoint geographies where gaps between observed and potential levels have narrowed or widened over time. Findings Between 1990 and 2015, nearly all countries and territories saw their HAQ Index values improve; nonetheless, the difference between the highest and lowest observed HAQ Index was larger in 2015 than in 1990, ranging from 28.6 to 94.6. Of 195 geographies, 167 had statistically significant increases in HAQ Index levels since 1990, with South Korea, Turkey, Peru, China, and the Maldives recording among the largest gains by 2015. Performance on the HAQ Index and individual causes showed distinct patterns by region and level of development, yet substantial heterogeneities emerged for several causes, including cancers in highest-SDI countries; chronic kidney disease, diabetes, diarrhoeal diseases, and lower respiratory infections among middle-SDI countries; and measles and tetanus among lowest-SDI countries. While the global HAQ Index average rose from 40.7 (95% uncertainty interval, 39.0-42.8) in 1990 to 53.7 (52.2-55.4) in 2015, far less progress occurred in narrowing the gap between observed HAQ Index values and maximum levels achieved; at the global level, the difference between the observed and frontier HAQ Index only decreased from 21.2 in 1990 to 20.1 in 2015. If every country and territory had achieved the highest observed HAQ Index by their corresponding level of SDI, the global average would have been 73.8 in 2015. Several countries, particularly in eastern and western sub-Saharan Africa, reached HAQ Index values similar to or beyond their development levels, whereas others, namely in southern sub-Saharan Africa, the Middle East, and south Asia, lagged behind what geographies of similar development attained between 1990 and 2015. Interpretation This novel extension of the GBD Study shows the untapped potential for personal health-care access and quality improvement across the development spectrum. Amid substantive advances in personal health care at the national level, heterogeneous patterns for individual causes in given countries or territories suggest that few places have consistently achieved optimal health-care access and quality across health-system functions and therapeutic areas. This is especially evident in middle-SDI countries, many of which have recently undergone or are currently experiencing epidemiological transitions. The HAQ Index, if paired with other measures of health-systemcharacteristics such as intervention coverage, could provide a robust avenue for tracking progress on universal health coverage and identifying local priorities for strengthening personal health-care quality and access throughout the world. Copyright (C) The Author(s). Published by Elsevier Ltd.Peer reviewe
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017
Background:
Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with the estimates of the numbers of deaths in the GBD. The present iteration of the GBD, GBD 2017, improves on previous assessments and provides timely estimates of the mortality experience of populations globally.
Methods:
The GBD uses all available data to produce estimates of mortality rates between 1950 and 2017 for 23 age groups, both sexes, and 918 locations, including 195 countries and territories and subnational locations for 16 countries. Data used include vital registration systems, sample registration systems, household surveys (complete birth histories, summary birth histories, sibling histories), censuses (summary birth histories, household deaths), and Demographic Surveillance Sites. In total, this analysis used 8259 data sources. Estimates of the probability of death between birth and the age of 5 years and between ages 15 and 60 years are generated and then input into a model life table system to produce complete life tables for all locations and years. Fatal discontinuities and mortality due to HIV/AIDS are analysed separately and then incorporated into the estimation. We analyse the relationship between age-specific mortality and development status using the Socio-demographic Index, a composite measure based on fertility under the age of 25 years, education, and income. There are four main methodological improvements in GBD 2017 compared with GBD 2016: 622 additional data sources have been incorporated; new estimates of population, generated by the GBD study, are used; statistical methods used in different components of the analysis have been further standardised and improved; and the analysis has been extended backwards in time by two decades to start in 1950.
Findings:
Globally, 18·7% (95% uncertainty interval 18·4–19·0) of deaths were registered in 1950 and that proportion has been steadily increasing since, with 58·8% (58·2–59·3) of all deaths being registered in 2015. At the global level, between 1950 and 2017, life expectancy increased from 48·1 years (46·5–49·6) to 70·5 years (70·1–70·8) for men and from 52·9 years (51·7–54·0) to 75·6 years (75·3–75·9) for women. Despite this overall progress, there remains substantial variation in life expectancy at birth in 2017, which ranges from 49·1 years (46·5–51·7) for men in the Central African Republic to 87·6 years (86·9–88·1) among women in Singapore. The greatest progress across age groups was for children younger than 5 years; under-5 mortality dropped from 216·0 deaths (196·3–238·1) per 1000 livebirths in 1950 to 38·9 deaths (35·6–42·83) per 1000 livebirths in 2017, with huge reductions across countries. Nevertheless, there were still 5·4 million (5·2–5·6) deaths among children younger than 5 years in the world in 2017. Progress has been less pronounced and more variable for adults, especially for adult males, who had stagnant or increasing mortality rates in several countries. The gap between male and female life expectancy between 1950 and 2017, while relatively stable at the global level, shows distinctive patterns across super-regions and has consistently been the largest in central Europe, eastern Europe, and central Asia, and smallest in south Asia. Performance was also variable across countries and time in observed mortality rates compared with those expected on the basis of development.
Interpretation:
This analysis of age-sex-specific mortality shows that there are remarkably complex patterns in population mortality across countries. The findings of this study highlight global successes, such as the large decline in under-5 mortality, which reflects significant local, national, and global commitment and investment over several decades. However, they also bring attention to mortality patterns that are a cause for concern, particularly among adult men and, to a lesser extent, women, whose mortality rates have stagnated in many countries over the time period of this study, and in some cases are increasing
Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
Exclusive breastfeeding (EBF)—giving infants only breast-milk for the first 6 months of life—is a component of optimal breastfeeding practices effective in preventing child morbidity and mortality. EBF practices are known to vary by population and comparable subnational estimates of prevalence and progress across low- and middle-income countries (LMICs) are required for planning policy and interventions. Here we present a geospatial analysis of EBF prevalence estimates from 2000 to 2018 across 94 LMICs mapped to policy-relevant administrative units (for example, districts), quantify subnational inequalities and their changes over time, and estimate probabilities of meeting the World Health Organization’s Global Nutrition Target (WHO GNT) of ≥70% EBF prevalence by 2030. While six LMICs are projected to meet the WHO GNT of ≥70% EBF prevalence at a national scale, only three are predicted to meet the target in all their district-level units by 2030
Avaliação do sistema informático perinatal (SIP CLAP OPS) no monitoramento da assistência hospitalar perinatal em Minas Gerais
Exportado OPUSMade available in DSpace on 2019-08-13T16:17:12Z (GMT). No. of bitstreams: 1
maria_albertina_santiago_rego.pdf: 1824067 bytes, checksum: 7ee9ac9a5aec58e5b916854039545e3f (MD5)
Previous issue date: 25Objetivos: Avaliar a qualidade da informação e alguns indicadores perinatais do Sistema Informático Perinatal do Centro Latino Americano de Perinatologia da Organização Panamericana de Saúde (SIP-CLAP), e sua utilização para monitoramento da assistência hospitalar perinatal em Minas Gerais. A pesquisa foi desenvolvida em três etapas: 1)analisar a qualidade da informação do SIP-CLAP em maternidades de referência em atenção perinatal de Belo Horizonte (Artigo 1); 2) analisar alguns indicadores maternos e neonatais gerados pelo SIP-CLAP do Hospital das Clínicas da Universidade Federal de Minas Gerais (HC-UFMG) em dois períodos, 1995-98 e 2003-06 (Artigo 2); e 3)identificar as maternidades do Estado que implantaram o programa e avaliar sua utilização pelos profissionais da assistência nessas maternidades (Artigo 3). Metodologia: Para avaliar a qualidade da informação do SIP-CLAP foram analisadas amostras aleatórias sistemáticas de histórias clínicas perinatais (HCP-SIP) e prontuáriosmédicos correspondentes, coletados durante a assistência (componente de completude) e após armazenamento da informação no banco de dados eletrônico do SIP-CLAP (componente de confiabilidade) em duas maternidades de Belo Horizonte onde o programa estava implementado em 2004. Indicadores maternos e neonatais gerados pelo SIP-CLAP foram então analisados em uma dessas maternidades, o HC-UFMG, em dois períodos, 1995-1998 e 2003-2006, antes e após mudanças no fluxo hospitalar assistencial perinatal no município. Para identificar a utilização do SIP-CLAP nas maternidades de Minas Geraisfoi aplicado questionário estruturado aos gestores e, posteriormente, em amostra aleatória de 142 profissionais da assistência hospitalar ao parto e nascimento de três maternidades de referência em atenção perinatal de Belo Horizonte, onde o SIP-CLAP estava implementado em 2005. Resultados: A proporção de completude de variáveis selecionadas da HCP-SIP durante a assistência foi em média 72% no Hospital 1 e 86% no Hospital 2. Após pesquisa em prontuário, o ganho percentual médio no registro global da informação foi de 18% e 7%,respectivamente. A confiabilidade da informação armazenada no banco de dados eletrônico apresentou globalmente índices excelentes de concordância nos dois hospitais. A análise do perfil da população e dos principais indicadores de saúde perinatal gerados pelo SIP-CLAP no HC-UFMG permitiu identificar que, apesar do aumento importante novolume assistencial após reestruturação do fluxo hospitalar perinatal em Belo Horizonte, as características populacionais permaneceram estáveis em geral, com redução significativa da mortalidade neonatal e hospitalar, principalmente de recém-nascidos de muito baixo peso ao nascer. Foram identificados somente três hospitais com implantação do programa em Minas Gerais em 2005. A quase totalidade dos profissionais entrevistados nestes hospitais reconheceu a importância do registro da informação sistematizada durante a assistência ao parto e nascimento. A maioria deles define a HCP-SIP c omo um instrumentoque contempla informações básicas necessárias para a assistência individual, mas não responde totalmente às necessidades de registro clínico durante o processo assistencial, limitação esta detectada principalmente pelos pediatras. Verificou-se que dois terços dos profissionais registram a informação durante a assistência, mas apenas 37% deles utilizam a HCP-SIP com o objetivo principal de definir condutas clínicas e somente 19% utilizam o banco de dados eletrônico gerado pelo programa. A capacitação dos profissionais para opreenchimento da HCP-SIP ocorreu para 66% dos entrevistados e somente um quarto deles foi capacitado para o manuseio dos programas de análise eletrônica. Conclusões: A qualidade da informação do SIP-CLAP, avaliada pelo preenchimento da HCP-SIP durante a assistência e a confiabilidade da informação arquivada no banco de dados eletrônico do SIP-CLAP, somada às características do programa, indicam que o Sistema Informático Perinatal pode ser um bom instrumento para monitoramento da assistência hospitalar ao parto e nascimento objetivando a melhoria da qualidade da assistência perinatal. O reconhecimento pela maioria dos profissionais da importância de registro sistematizado de informação essencial, fundamentada em indicadores assistenciais básicos, identificou a possibilidade de implementação de sistema informático paramonitoramento da assistência perinatal integrado às funções assistenciais na rede hospitalar de Minas Gerais. As falhas identificadas no processo de implementação do programa nos hospitais estudados podem servir de apoio às instituições e gestores na implantação deprogramas de melhoria da qualidade da assistência.Objective: To assess the quality of information and some perinatal indicators of the Perinatal Information System of the Latin-American Center of Perinatology (SIP-CLAP) of the Pan American Health Organization, and their use to monitor perinatal hospital care inMinas Gerais. The research was carried out in three stages: 1) analysis of the quality of the SIP-CLAP information in reference maternity hospitals focused on perinatal care in Belo Horizonte (Article 1); 2) analysis of some maternal and neonatal indicators collected by the SIP-CLAP of the Hospital of Clinics of the University of Minas Gerais (HC-UFMG) in twoperiods, 1995-98 and 2003-06 (Article 2); 3) identification of the State maternity hospitals that have implemented the program and assessment of its use by the healthcare professionals in these maternity hospitals (Article 3). Methodology: In order to assess the quality of the SIP-CLAP information, systematic random samples of perinatal clinical histories (HCP-SIP) were analyzed, as well as their corresponding medical records collected during the medical assistance (completion component) and after the information was stored in the SIP-CLAP`s electronic database (reliability component) in two maternity hospitals of Belo Horizonte where the program was set up in 2004. Maternal and neonatal indicators generated by SIP-CLAP were then analyzed in one of these maternity hospitals, the HC-UFMG, in two periods, 1995-1998 and2003-2006, before and after the changes in the flow of perinatal hospital care in the city. To identify the use of SIP-CLAP in the maternity hospitals of Minas Gerais, a designed questionnaire was applied to the managers, and later to a random sample of 142 professionals of the hospital birth care area in three perinatal care reference maternity hospitals of Belo Horizonte where SIP-CLAP/OPS was implemented in 2005. Results: The completion rate of the selected HCP-SIP variables during the medicalassistance was 72 % on average in Hospital 1 and 86 % in Hospital 2. After the survey using the medical records, the average gain rate in the total record of information was 18% and 7 % respectively. On the whole, reliability of the information stored in the electronic database showed excellent agreement rates in both hospitals. The analysis of the population profile as well as of the major perinatal health indicators generated by SIP-CLAP at HCUFMG enabled us to acknowledge that, despite the considerable increase in the volume of medical assistance after the changes in the structure of the hospital flow of perinatal care inBelo Horizonte, the characteristics of the population remained generally stable, with significant decrease in neonatal and hospital mortality, mainly of underweight newborns. In 2005, the program had been set up in only three hospitals in Minas Gerais. Nearly all professionals interviewed at these hospitals acknowledged the importance of recording the systematized information during birth medical assistance. Most of them define HCP-SIP as a tool which stores the basic necessary information for individual care, but they do not fully meet the needs of clinical records during the assistance process, a limitation that has beenidentified mainly by pediatricians. It was noted that two-thirds of the professionals recorded the information during the medical assistance, but only 37% used HCP-SIP with the main purpose of defining clinical procedures, and just 19% utilized the electronic database generated by the program. Sixty-six percent of the interviewed professionals were qualified to fill out the HCP-SIP form, but only one-quarter of these were qualified to handle the electronic analysis programs. Conclusions: The quality of the SIP-CLAP information assessed by filling out the HCP-SIPform during the medical assistance, and the reliability of the information stored in the SIPCLAP electronic database added to the characteristics of the program indicate that the Perinatal Information System can be a good tool for monitoring hospital birth care aiming at improving the quality of perinatal care. The fact that most professionals acknowledge the importance of systematized record of essential information based on basic indicators of health care identified the possibility of setting up an information system for monitoring perinatal care integrated with the health care activities in the Minas Gerais hospital network. The flaws identified in the process of setting up the program in the studied hospitals may be used as support for institutions and managers in the implementation of programs to improve health care standards